The Pharmacy Times® Pharmacy Technician Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to specialty pharmacists.
July 7th 2025
The new formulation contains little IgA, reducing possible risks associated with infusion in patients with primary immunodeficiency.
Esketamine Nasal Spray Receives FDA Approval for Treatment-Resistant Depression
March 6th 2019Officials with the FDA have approved esketamine CIII nasal spray (Spravato, Janssen Pharmaceutical Companies of Johnson & Johnson) for use in conjunction with an oral antidepressant in adults with treatment-resistant depression.
Read More